Jove
Visualize
联系我们

相关概念视频

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.5K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Long-term outcomes of evolving treatment regimens in Ewing sarcoma survivors diagnosed 1970-1999: A report from the Childhood Cancer Survivor Study.

Cancer·2026
Same author

A modified Delphi consensus on tenosynovial giant cell tumour and giant cell tumour of bone : a report from the Birmingham Orthopaedic Oncology Meeting (BOOM).

The bone & joint journal·2026
Same author

Complications of PI to PIII hemipelvic resections for intermediate and malignant tumours : a systematic review and meta-analysis.

Bone & joint open·2026
Same author

Team Approach: Diagnosis and Management of Pediatric Pelvic Ewing Sarcoma.

JBJS reviews·2026
Same author

Sex differences in physical activity, psychosocial determinants, and symptom outcomes in knee osteoarthritis: a cross-sectional analysis of a Hispanic/Latino-predominant cohort.

Rheumatology international·2026
Same author

IlluminOss photodynamic bone stabilization system: Retrospective cohort review of clinical and peri-operative imaging complications.

Clinical imaging·2026
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关实验视频

Updated: Jun 7, 2025

Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy
08:54

Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy

Published on: May 8, 2018

14.2K

软组织肉瘤的支臂治疗:保持局部控制,同时最大限度地减少并发症.

Julien Montreuil1, Eric Kholodovsky2, Moses Markowitz2

  • 1Department of Orthopaedics, University of Miami Miller School of Medicine, Miami, Florida, USA.

Journal of surgical oncology
|November 19, 2024
PubMed
概括

高剂量支臂疗法 (BRT) 与用于软组织肉瘤的新辅助外部束辐射疗法 (Neo-EBRT) 相比,具有较低的伤口并发症风险,具有类似的局部控制率.

关键词:
支臂疗法 (brachytherapy) 是一种治疗方法.软组织肉瘤软组织肉瘤伤口并发症 伤口并发症

更多相关视频

Stereotactic Radiosurgery for Gynecologic Cancer
10:35

Stereotactic Radiosurgery for Gynecologic Cancer

Published on: April 17, 2012

18.1K
A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing Neoadjuvant Therapies
07:15

A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing Neoadjuvant Therapies

Published on: July 28, 2020

9.5K

相关实验视频

Last Updated: Jun 7, 2025

Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy
08:54

Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy

Published on: May 8, 2018

14.2K
Stereotactic Radiosurgery for Gynecologic Cancer
10:35

Stereotactic Radiosurgery for Gynecologic Cancer

Published on: April 17, 2012

18.1K
A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing Neoadjuvant Therapies
07:15

A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing Neoadjuvant Therapies

Published on: July 28, 2020

9.5K

科学领域:

  • 在瘤学瘤学.
  • 辐射瘤学 辐射瘤学
  • 手术瘤学手术瘤学

背景情况:

  • 高度软组织肉瘤需要有效的治疗策略.
  • 对比不同的辐射方式对于优化患者的治疗结果至关重要.
  • 支臂疗法 (BRT) 和外部束辐射疗法 (EBRT) 是关键的治疗选择.

研究的目的:

  • 为了比较BRT的临床和瘤结果与手术前和术后EBRT.
  • 评估不同辐射技术在软组织肉瘤治疗中的有效性和安全性.
  • 根据患者和疾病特征,确定最佳的辐射策略.

主要方法:

  • 对144名软组织肉瘤患者进行了回顾性队列研究.
  • 对接受BRT,新辅助EBRT (Neo-EBRT) 或辅助EBRT (AD-EBRT) 治疗的患者的分析.
  • 治疗组间的伤口并发症和局部复发率的比较.

主要成果:

  • 与BRT (25%) 和AD-EBRT (28.3%) 相比,新EBRT组的伤口并发症发生率明显更高 (50%).
  • 多变量分析证实Neo-EBRT与BRT (p=0.007) 的伤口并发症风险增加.
  • 在治疗组之间没有观察到局部复发 (LR) 风险的显著差异 (p=0.28).

结论:

  • 支臂疗法是软组织肉瘤的宝贵治疗方法,具有临床和后勤方面的好处.
  • 与新型EBRT相比,BRT显示伤口并发症的风险较低.
  • 支臂疗法提供了与EBRT相比较的局部控制,使其在特定情况下成为一个有利的选择.